Acquisitions

Join the AddLife Family

We develop your company through active ownership through a successful process for integration and growth.

Do you have a profitable life science company in a leading niche position with opportunities to grow or are you facing a generational shift but want your company to keep the identity?

AddLife offers an attractive option with a decentralized business model. The subsidiaries continue to run their business with current management and under their own brand. AddLife adds financial stability, skills and tools that make it easier and more efficient to grow the business. For example, we have AddLife Academy and knowledge-sharing networks.

Contact us via the form below or e-mail Tom Tryde directly, and let's see what opportunities we have together.

Extensive experience of acquisitions

579Untitled

What are we looking for?

  • European life science companies
  • Strong position in a market niche
  • Profitable and well-managed companies
  • Corporate philosophy and culture in line with AddLife
  • Sustainable business model
  • Continued commitment from management and key employees

 

What are we offering?

  • Financial stability
  • Collaboration and knowledge sharing with other AddLife companies
  • AddLife Academy offers trainings in e.g. sales and leadership
  • Decentralised business model where the company keeps its brand, identity and culture
  • Competence and resources within sustainability, digitalisation and business development
  • AddLife acquires LEHNEN GmbH

    AddLife acquires LEHNEN GmbH, a leading German manufacturer of products and system solutions for accessible and adapted bathrooms, used in homes, hospitals, care homes and public environments. The company has annual sales of approximately EUR 5 million, around 30 employees and is part of AddLife’s Business Area Medtech.

    To Lehnen
    IMG 7701 Crop
  • AddLife acquires Unicam Sistemas Analíticos

    AddLife acquires Unicam Sistemas Analíticos, a leading Portuguese distributor of advanced analytical laboratory equipment to universities, research institutions and industrial customers, with annual revenue of approximately EUR 10 million and 20 employees. Unicam offers instruments, consumables, technical support, service and training in chromatography, spectrometry, and microwave technology and is part of AddLife’s Business Area Labtech.

    To Unicam
    Unicam 2026
  • AddLife acquires CoaChrom Diagnostica

    AddLife acquires CoaChrom Diagnostica GmbH, an Austrian niche company specialising in advanced coagulation diagnostics for clinical laboratories and the pharmaceutical industry, with approximately EUR 10 million in sales and 10 employees. CoaChrom will become part of AddLife’s business area, Labtech, and will continue to operate under its own brand in line with AddLife’s decentralised business model. CoaChrom is an Austrian niche company focusing on advanced coagulation diagnostics for clinical laboratories and the pharmaceutical industry.

    To CoaChrome
    6730.jpg
  • AddLife acquires BioSpectrum

    AddLife acquires BioSpectrum Ltd, a fast‑growing distributor of surgical solutions in the fields of urology, gynaecology and general surgery in the UK. The company will be included within AddLife’s Business Area Medtech. BioSpectrum generates an annual revenue of approximately GBP 6 million and has 16 employees.

    To BioSpectrum
    img-20260312-wa0016.webp
  • AddLife acquires Opitek International

    AddLife has acquired Opitek International ApS (“Opitek”), a manufacturer specializing in patient positioning. Opitek, a Danish MedTech company renowned for its specialized solutions in safe and efficient patient positioning before and during surgery that address both staff ergonomics and patient safety. The company will become part of Mediplast, a company within AddLife’s Business Area Medtech and has yearly sales of approximately 8 million DKK.

    To opitek international
    Opitek
  • AddLife acquires Pharmacold

    AddLife acquires Pharmacold A/S, a leading Danish specialist in refrigeration technology and service for the pharmaceutical and healthcare sectors. Pharmacold will become a subsidiary of Holm & Halby, a company within AddLife’s business Area Labtech. Pharmacold delivers advanced, customised solutions for temperature-controlled storage, including installation, service, and support of refrigeration and freezer systems, climate control systems, and mobile low-temperature units. Pharmacold, with a current revenue of EUR 3.4 million, operates primarily in Denmark.

    To Pharmacold
    IMG 0822 Mp 1000
  • Quote

    When working with Italy

    Mariateresa Taliento, Paola Ruggeri and Greta Rizzi, Biomedica Italia

    When working with Italy, it is important to know that personal relationships are fundamental. Italians prefer warm communication and often start meetings with informal conversations to establish trust. Decisions can be influenced by emotions and context, not just by data. According to the Lewis Model, Italy is a “multi-active” culture: it is necessary to be flexible, ready to discuss several topics at the same time, and open to negotiation. Meetings may be less structured than in other countries, but this encourages the search for creative solutions and the strengthening of professional relationships.

    Image (1)
  • Quote

    Right chemistry from the start

    - Michael Hartman, entrepreneur and former co-owner of BioCat

    When we began considering the future of BioCat, I realized that selling the company was about much more than just the numbers. While the financial side is important, what really mattered was finding a partner who would respect our values, support our team, and help us continue building on our strong foundation.

    AddLife Stories
    Biocat 2022
  • Quote

    Smooth and efficient acquisition process

    - Kenneth Söderhäll, MD JK Lab Nordic

    Discussions about an extended collaboration with BergmanLabora began in the fall of 2018. Since then, there have been many cups of coffee and an exchange of thoughts and ideas. Once we agreed that it would be a good idea for the companies to merge, it was presented to AddLife. After that, it went quickly, from presented business idea to completed acquisition in less than six months.

    Bergmanlabora Jklab

AddLife´s Acquisitions since listing

Here you can find more information about our subsidiaries. Click on a country to see our acquisitions since AddLife was listed 2016.

Year

Acquisitions

Country

Time

Net Sales, SEKm

No of employees

Business Area

2026

LEHNEN GmbH

Germany

October

50

30

Medtech

Unicam Sistemas Analíticos

Portugal

September

111

20

Labtech

CoaChrom Diagnostica

Austria

April

108

10

Labtech

BioSpectrum Ltd

Great Britain

March

74

16

Medtech

2025

Opitek International ApS

Denmark

December

9

2 

Medtech

Pharmacold A/S

Denmark

December

38

20

Labtech

Edge Medical Ltd

Great Britain

April

90

20

Medtech

2024

BonsaiLab

Spain

July

90

13

Labtech

2023

Emmat Medical Ltd

Great Britain

September

28

4

Medtech

2022

JK Lab Nordic AB

Sweden

July

24

6

Labtech

BioCat GmbH

Germany

April

90

20

Labtech

O’Flynn Medical Ltd

Ireland

April

64

36

Medtech

Business from Telia Health Monitoring

Sweden

March

4

7

Medtech

MBA Incorporado S.L

Spain

January

670

285

Medtech

2021

Camanio AB

Sweden

December

13

18

Medtech

Fischer Medical ApS

Denmark

November

60

12

Medtech

Bio-Connect Group

Benelux

September

140

31

Labtech

Healthcare 21 Group

Irland, UK

April

1 700

450

Medtech

Vision Ophthalmology Group

Switzerland, Germany, the UK, Poland

April

700

190

Medtech

2020

Biomedica Italia s.r.l.

Italy

December

80

17

Medtech

Zafe Care Systems AB

Sweden

October

34

21

Medtech

DACH Medical Group

Austria, Switzerland and Germany

October

140

23

Medtech

Ropox A/S

Denmark

October

91

73

Medtech

Technipro-Pulmomed Pty Limited

Australia

August

12

5

Medtech

Euroclone S.p.A.

Italy

January

280

58

Labtech

2019

Funksjonsutstyr AS

Norway

December

50

6

Medtech

Fysionord i Sollefteå

Sweden

September

6

2

Medtech

Lab-Vent Controls A/S and Koldt & Ryø El A/S

Denmark

August

52

20

Labtech

Business from Wellspect HealthCare

Sweden

April

170

14

Medtech

2018

Biomedica Medizinprodukte GmbH

Austria

December

650

280

Labtech

Laboren ApS

Denmark

December

10

2

Labtech

Väinö Korpinen Oy

Finland

July

80

15

Medtech

Food Diagnostics AB

Sweden

March

10

3

Labtech

Ossano Scandinavia AB

Sweden

February

22

5

Medtech

2017

Krabat AS

Norge

July

30

13

Medtech

Hepro AS

Norge

March

165

40

Medtech

TM Techno Medica AB

Sweden

January

30

5

Medtech

2016

Biolin Scientific AB

Sweden

December

100

68

Labtech

Svan Care AB

Sweden

October

35

13

Medtech

V-Tech AB and Esthe-Tech AB

Sweden

April

50

11

Medtech

  • Quote

    A place for your business to belong

    Nathan Pettitt, Vice President Hospital 

    When a founder considers selling, the numbers of course matter, but many other factors are important in the decision process.

    In a recent acquisition process, the company owner was exploring several options in terms of what type of buyer they should consider selling to. I explained that our process would take time because we wanted to understand the company, meet its people, and make sure the cultural fit was right. We don’t want to rush since it’s a long-term commitment we look for, not short-term and then sell again.

    The key question was simple: could the owner look employees and the local community in the eye two years later and still feel they had chosen the right long-term owner?

    We discussed the company’s future plans, succession and how AddLife’s leadership programmes, experienced boards and network of specialists could support growth to the next stage.

    The aim was not to change what already worked, but to preserve the entrepreneurial character while adding the structure, expertise and resources needed to grow. That is what AddLife can offer: a long-term home where a strong business can belong and continue developing.

    CONTACT US
    IMG 20260312 WA0022 Nathan Vid Bord Crop
  • Quote

    The courage to take the next step

    Therese Wilson, Vice President Homecare

    “We know we have to do the work. What we expect from you is to provide a little more courage.”

    When I speak with company owners about joining AddLife, I explain that our decentralised model comes with clear expectations: their leaders continue to run their own business. They must drive the initiatives and commercial momentum. What we provide is support.

    One business owner described that support particularly well: “We know we have to do the work. What we expect from AddLife is a little more courage.”

    Running a family business alone, with employees depending on your decisions, can make investments feel risky. With AddLife behind you, you have room to act, learn, and move forward. You remain responsible for your company, while gaining the resources, network and specialist expertise of a larger group.

    This is particularly relevant for manufacturing companies with proprietary products, where long-term ownership can help protect what makes the business unique while supporting the next phase of development and growth.

    That combination can give entrepreneurial companies the confidence to invest, develop and grow over time. I look forward to helping more strong businesses take that next step.

    CONTACT US
    Therese Wilson 2026 Crop
  • Quote

    Customer proximity creates trust. Deep customer understanding drives growth.

    Kai Rantanen, Vice President Diagnostics

    When you consider selling your life science distribution company, I believe the first question isn’t just about price. It is whether the buyer understands what you have built. For many companies, customer proximity is one of the strongest assets. It builds trust through regular contact, strong technical service, customer service, and people who know customers well. Over time, competitors find it hard to replace those relationships. This is also why deep customer understanding drives growth. When you know your customers and their needs and products well, you can see where new opportunities may come from. It also makes the company more attractive to suppliers who want the right distributor for their products.

    As part of AddLife, a company can stay close to its customers and keep making its own decisions, while gaining access to boards, specialist colleagues, supplier relationships, and a European network of companies in the same situation. For you as an owner, that means more support, more opportunities and a stronger future for your company.

    CONTACT US
    6730 Crop
  • Quote

    Trend spotting with entrepreneurial freedom

    Mattias Bengtsson, Vice President Biomedical and Research

    “The purpose is not to centralise decisions, but to create opportunities.”

    For an entrepreneur considering succession, selling is rarely only about cashing in. It is also about ensuring the company, its employees, and its legacy can keep developing. That is where AddLife’s decentralised model matters. The company keeps its name, customer and supplier relationships, organisation and local decision-making. In many ways, it is business as usual, but with access to a wider network of companies facing similar questions.

    One practical example is our Innovation Scouting Group, which helps identify the next generation of suppliers and niche products through scientific conferences and research-focused meetings. For a smaller specialist business, it can be difficult to have the resources to stay close to every new trend. At AddLife, those opportunities become easier to see earlier, while each company still decides what fits its own business. That is our strength, continuity and entrepreneurial freedom that gives new possibilities for growth.

    CONTACT US
    IMG 8838 Crop
ADD Lonsamhet Vit

Investors

Labtech

Labtech

Medtech

Medtech

ADD Dna 2 Vit

About AddLife

Being part of the AddLife family

franco-aiolfi-euroclone.webp
11 February 2026
Continuing the Euroclone story

Selling to AddLife means continuing the Euroclone story, not ending it.

Euroclone
04 November 2025 | Biomedica Italia
Strong company values

Positive feedback from entrepreneurs within the AddLife family gave me the confidence to join,

07 October 2025 | Bio-Connect
Authentic company culture

From the very beginning, I was struck by AddLife’s personal approach and authentic company culture. They didn’t just see a business, they saw people, potential, and purpose.

23 September 2025 | BioCat
Right chemistry from the start

Every step of the process, from initial talks to signing the contract, was pragmatic, straightforward, and quick.

See all news

Contact us!

Christian Karlsson (5)

Christian Karlsson

Vice President Strategy & Business Development

christian.karlsson@add.life

Tom Tryde

Tom Tryde

M&A Manager

tom.tryde@add.life